The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients – preliminary report

INTRODUCTION: Methotrexate (MTX) has anti-proliferative and anti-inflammatory effects in psoriasis. Moreover, low doses can reduce the risk of developing cardiovascular diseases. It turns out that psoriasis and atherosclerosis have a similar pathogenetic mechanism: the same pro-inflammatory cytokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Owczarczyk-Saczonek, Agnieszka, Drozdowski, Marek, Maciejewska-Radomska, Agata, Choszcz, Dariusz, Placek, Waldemar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872240/
https://www.ncbi.nlm.nih.gov/pubmed/29599672
http://dx.doi.org/10.5114/ada.2017.71358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872240/
https://www.ncbi.nlm.nih.gov/pubmed/29599672
http://dx.doi.org/10.5114/ada.2017.71358

Ejemplares similares